0001209191-23-014701.txt : 20230302
0001209191-23-014701.hdr.sgml : 20230302
20230302163314
ACCESSION NUMBER: 0001209191-23-014701
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230302
DATE AS OF CHANGE: 20230302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simon Lynn T
CENTRAL INDEX KEY: 0001598823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15925
FILM NUMBER: 23699576
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC
CENTRAL INDEX KEY: 0001108109
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 133893191
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-465-7000
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/
DATE OF NAME CHANGE: 20000229
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-01
0
0001108109
COMMUNITY HEALTH SYSTEMS INC
CYH
0001598823
Simon Lynn T
4000 MERIDIAN BOULEVARD
FRANKLIN
TN
37067
0
1
0
0
President and CMO
Common Stock
2023-03-01
4
M
0
52500
0.00
A
404474
D
Common Stock
2023-03-01
4
A
0
40000
0.00
A
444474
D
Common Stock
2023-03-01
4
F
0
34596
6.15
D
409878
D
Performance Based Restricted
0.00
2023-03-01
4
M
0
52500
0.00
D
Common Stock
52500
0
D
Performance Based Restricted
0.00
2023-03-01
4
A
0
80000
0.00
A
Common Stock
80000
80000
D
Stock Options (Right to Buy)
6.15
2023-03-01
4
A
0
40000
0.00
A
2024-03-01
2033-02-28
Common Stock
40000
40000
D
Performance Based Restricted
0.00
Common Stock
80000
80000
D
Performance Based Restricted
0.00
Common Stock
80000
80000
D
Stock Options (Right to Buy)
4.99
2020-03-01
2029-02-28
Common Stock
26250
26250
D
Stock Options (Right to Buy)
4.93
2021-03-01
2030-02-28
Common Stock
26250
26250
D
Stock Options (Right to Buy)
8.81
2022-03-01
2031-02-28
Common Stock
40000
40000
D
Stock Options (Right to Buy)
10.18
2023-03-01
2032-02-29
Common Stock
40000
40000
D
The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020.
The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
Christopher G. Cobb, Attorney in Fact for Lynn T. Simon
2023-03-02